Literature DB >> 23304996

Altitude exposures during commercial flight: a reappraisal.

Neil B Hampson1, David A Kregenow, Anne M Mahoney, Steven H Kirtland, Kathleen L Horan, James R Holm, Anthony J Gerbino.   

Abstract

BACKGROUND: Hypobaric hypoxia during commercial air travel has the potential to cause or worsen hypoxemia in individuals with pre-existing cardiopulmonary compromise. Knowledge of cabin altitude pressures aboard contemporary flights is essential to counseling patients accurately about flying safety. The objective of the study was to measure peak cabin altitudes during U.S. domestic commercial flights on a variety of aircraft.
METHODS: A handheld mountaineering altimeter was carried by the investigators in the plane cabin during commercial air travel and peak cabin altitude measured. The values were then compared between aircraft models, aircraft classes, and distances flown.
RESULTS: The average peak cabin altitude on 207 flights aboard 17 different aircraft was 6341 +/- 1813 ft (1933 m +/- 553 m), significantly higher than when measured in a similar fashion in 1988. Peak cabin altitude was significantly higher for flights longer than 750 mi (7085 +/- 801 ft) compared to shorter flights (5160 +/- 2290 ft/1573 +/- 698 m). Cabin altitude increased linearly with flight distance for flights up to 750 mi in length, but was independent of flight distance for flights exceeding 750 mi. Peak cabin altitude was less than 5000 ft (1524 m) in 70% of flights shorter than 500 mi. Peak cabin altitudes greater than 8000 ft (2438 m) were measured on approximately 10% of the total flights.
CONCLUSIONS: Peak cabin altitude on commercial aircraft flights has risen over time. Cabin altitude is lower with flights of shorter distance. Physicians should take these factors into account when determining an individual's need for supplemental oxygen during commercial air travel.

Entities:  

Mesh:

Year:  2013        PMID: 23304996     DOI: 10.3357/asem.3438.2013

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  7 in total

1.  Safety of commercial airflight in patients with brain tumors: a case series.

Authors:  Michelle Phillips; Marlon Saria; Amy Eisenberg; Daniel F Kelly; Garni Barkhoudarian
Journal:  J Neurooncol       Date:  2018-05-17       Impact factor: 4.130

Review 2.  Aeromedical Transport of Critically Ill Patients: A Literature Review.

Authors:  Alan Araiza; Melanie Duran; Salim Surani; Joseph Varon
Journal:  Cureus       Date:  2021-05-07

3.  Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information.

Authors:  Xiao Li; Jessilyn Dunn; Denis Salins; Gao Zhou; Wenyu Zhou; Sophia Miryam Schüssler-Fiorenza Rose; Dalia Perelman; Elizabeth Colbert; Ryan Runge; Shannon Rego; Ria Sonecha; Somalee Datta; Tracey McLaughlin; Michael P Snyder
Journal:  PLoS Biol       Date:  2017-01-12       Impact factor: 8.029

4.  Risk for intracranial pressure increase related to enclosed air in post-craniotomy patients during air ambulance transport: a retrospective cohort study with simulation.

Authors:  Helge Brändström; Anna Sundelin; Daniela Hoseason; Nina Sundström; Richard Birgander; Göran Johansson; Ola Winsö; Lars-Owe Koskinen; Michael Haney
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-05-12       Impact factor: 2.953

5.  In-Flight Hypoxemia in a Tracheostomy-Dependent Infant.

Authors:  Jason Quevreaux; Christopher Cropsey
Journal:  Case Rep Anesthesiol       Date:  2017-02-28

6.  Ketamine decreases inflammatory and immune pathways after transient hypoxia in late gestation fetal cerebral cortex.

Authors:  Eileen I Chang; Miguel A Zárate; Maria B Rabaglino; Elaine M Richards; Thomas J Arndt; Maureen Keller-Wood; Charles E Wood
Journal:  Physiol Rep       Date:  2016-03-31

7.  Altitude Acclimatization Alleviates the Hypoxia-Induced Suppression of Exogenous Glucose Oxidation During Steady-State Aerobic Exercise.

Authors:  Andrew J Young; Claire E Berryman; Robert W Kenefick; Allyson N Derosier; Lee M Margolis; Marques A Wilson; Christopher T Carrigan; Nancy E Murphy; John W Carbone; Jennifer C Rood; Stefan M Pasiakos
Journal:  Front Physiol       Date:  2018-07-09       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.